FDA Drug Application (010155) for MYTELASE by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number010155
Product Number002
FormTABLET;ORAL
Dosage10MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameMYTELASE
Active IngredientAMBENONIUM CHLORIDE



Back to FDA Applications sponsored by SANOFI AVENTIS US